CVM (STOCKS)
Cel-Sci Corporation
$1.010000
-0.070000 (-6.48%)
Prev close: $1.080000
Company Information
- Exchange
- XASE
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Geert R. Kersten
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $14.46M
- Employees
- 44
- P/E (TTM)
- -0.31
- P/B (TTM)
- 1.33
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
1
Strong Buy
3
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Mar 2024 (Q4)
|
$-2.70 | $-3.33 | +0.6330 | +18.99% |
|
Jun 2024 (Q3)
|
$-4.20 | $-3.94 | -0.2610 | -6.63% |
|
Mar 2024 (Q2)
|
$-4.20 | $-4.24 | +0.0420 | +0.99% |
|
Mar 2023 (Q4)
|
$-4.80 | $-4.85 | +0.0480 | +0.99% |
Financial Statements
| Revenues | -$505.83K |
| Benefits Costs and Expenses | -$55.99M |
| Costs And Expenses | -$50.67M |
| Operating Expenses | $22.22M |
| Depreciation and Amortization | $3.84M |
| Research and Development | $14.89M |
| Other Operating Expenses | $4.45M |
| Operating Income/Loss | -$22.22M |
| Income/Loss From Continuing Operations After Tax | $49.99M |
| Income/Loss From Continuing Operations Before Tax | $55.48M |
| Interest And Dividend Income, Operating | $171.00 |
| Interest Expense, Operating | $506.00K |
| Interest Income/Expense After Provision For Losses | -$505.83K |
| Interest Income/Expense Operating, Net | -$505.83K |
| Net Income/Loss | $49.99M |
| Net Income/Loss Attributable To Noncontrolling Interest | $72.69M |
| Net Income/Loss Attributable To Parent | -$22.70M |
| Net Income/Loss Available To Common Stockholders, Basic | -$22.70M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Provision For Loan, Lease, And Other Losses | $0.00 |
| Diluted Earnings Per Share | -$2.64 |
| Diluted Average Shares | 13,236,353 |
| Assets | $17.71M |
| Current Assets | $2.89M |
| Prepaid Expenses | $713.92K |
| Other Current Assets | $2.18M |
| Noncurrent Assets | $14.81M |
| Fixed Assets | $5.07M |
| Other Non-current Assets | $9.74M |
| Liabilities | $10.83M |
| Current Liabilities | $4.81M |
| Accounts Payable | $933.79K |
| Other Current Liabilities | $3.87M |
| Noncurrent Liabilities | $6.02M |
| Equity | $6.87M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $6.87M |
| Liabilities And Equity | $17.71M |
| Net Cash Flow From Operating Activities | -$16.65M |
| Net Cash Flow From Operating Activities, Continuing | -$16.65M |
| Net Cash Flow From Investing Activities | $9.06M |
| Net Cash Flow From Investing Activities, Continuing | $9.06M |
| Net Cash Flow From Financing Activities | $16.63M |
| Net Cash Flow From Financing Activities, Continuing | $16.63M |
| Net Cash Flow | $9.03M |
| Net Cash Flow, Continuing | $9.03M |
| Comprehensive Income/Loss | $49.99M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | $49.99M |
| Other Comprehensive Income/Loss | $0.00 |